Last reviewed · How we verify
Dibucaine (cinchocaine)
At a glance
| Generic name | cinchocaine |
|---|---|
| Drug class | Standardized Chemical Allergen [EPC] |
| Target | Sodium channel alpha subunits; brain (Types I, II, III) |
| Therapeutic area | Pain |
| Phase | FDA-approved |
Approved indications
- Not for use in children under 2 years
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dibucaine CI brief — competitive landscape report
- Dibucaine updates RSS · CI watch RSS
- portfolio CI